Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials

by Mark Nelson, Andrew Hill, Yvon van Delft, Christiane Moecklinghoff
Published 2014-01-01

No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogue...

by Ajantha Solomon, Surekha Tennakoon, Edwin Leeansyah, Jose Arribas, Andrew Hill, Yvon Van Delft, Christiane Moecklinghoff, Sharon R Lewin
Published 2014-01-01